Increased Risk of Lymphoma in Sicca Syndrome
- STUART S. KASSAN, M.D.;
- TERRY L. THOMAS, M.S.;
- HARALAMPOS M. MOUTSOPOULOS, M.D.;
- ROBERT HOOVER, M.D.;
- ROBERT P. KIMBERLY, M.D.;
- DANIEL R. BUDMAN, M.D.;
- JOSE COSTA, M.D.;
- JOHN L. DECKER, M.D.; and
- THOMAS M. CHUSED, M.D.
Abstract
The risk of cancer was ascertained in 136 women with sicca syndrome followed at the National Institutes of Health (NIH). Seven patients developed non-Hodgkin's lymphoma from 6 months to 13 years after their first admission to NIH. This was 43.8 times (P < 0.01) the incidence expected from the rates of cancer prevailing among women of the same age range in the general population during this time. In addition, three cases of Waldenström's macroglobulinemia occurred in this study group. Eight patients developed cancers other than lymphoma, similar to the number expected based on the rates prevailing in the general population. Patients with a history of parotid enlargement, splenomegaly, and lymphadenopathy had an increased risk of lymphoma. These clinical conditions did not appear to be early manifestations of undiagnosed lymphoma but rather seemed to identify a subgroup of patients with sicca syndrome with marked lymphoid reactivity, who had a particularly high risk of subsequently developing lymphoma.
Article and Author Information
-
▸From the Section of Clinical Immunology, Laboratory of Microbiology and Immunology, National Institute of Dental Research; Environmental Epidemiology Branch, National Cancer Institute; Arthritis and Rheumatism Branch, National Institute of Arthritis, Metabolism and Digestive Diseases; and Laboratory of Pathology, Division of Cancer Biology and Diagnosis, National Cancer Institute, National Institutes of Health; Bethesda, Maryland.
-
▸Requests for reprints should be addressed to Thomas M. Chused, M.D.; Building 10, Room 2B10; National Institutes of Health; Bethesda, MD 20014.
-
- Received July 10, 1978.
- Accepted July 31, 1978.
- ©1978 American College of Physicians
RSS Feeds









